I'm not sure what was mixed up, but something's not right with this paper's claim that ClpB levels are increased following rhodomyrtone treatment. In Table 1, the authors report that the accession number for spot is 15925538. The link to that accession is http://www.ncbi.nlm.nih.g... which while it does mention ClpB, it only refers to a 84 amino acid region of it as "C-terminal, D2-small domain, of ClpB protein." The identification, however, is not ClpB. Doing a full BLAST search reveals that gi|15925538 is actually ClpL, not ClpB (ClpB doesn't even show up in the first 100 hits).
So the ClpB parts of this paper and bibliography should be changed to reflect that the authors actually observed changes in ClpL.
